Followers | 11 |
Posts | 823 |
Boards Moderated | 0 |
Alias Born | 07/24/2015 |
Friday, September 08, 2023 6:34:02 PM
PYXS Long
Recent PYXS News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/25/2024 08:08:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/13/2024 08:26:30 PM
- Pyxis Oncology to Participate in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 08/29/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:25:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:19:48 PM
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference • GlobeNewswire Inc. • 07/29/2024 12:00:00 PM
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/28/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:17:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 11:56:02 AM
- Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger • GlobeNewswire Inc. • 06/10/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:00:32 PM
- Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/30/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:00:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:55:35 AM
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/28/2024 08:30:00 PM
- Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights • GlobeNewswire Inc. • 03/27/2024 11:30:00 AM
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023 • GlobeNewswire Inc. • 03/21/2024 11:30:00 AM
- Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA • GlobeNewswire Inc. • 03/13/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/08/2024 09:03:18 PM
- Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/07/2024 09:30:00 PM
- Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:02:43 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM